HRV analysis measures heart rate variability with millisecond precision — the most sensitive objective measure of autonomic balance, stress load and recovery capacity. Not a summary score on a smartwatch. A complete clinical analysis.
ECG-based R-R interval analysis · Time & frequency domain · Non-linear analysis
HRV does not measure how fast the heart beats — it measures the variation in time between each heartbeat. A healthy, well-regulated autonomic nervous system produces constantly varying intervals. Monotonous, uniform rhythm is a sign of stress, not health.
The autonomic nervous system is regulated by two branches: the sympathetic (activation, stress, fight-or-flight) and the parasympathetic (recovery, rest-and-digest). HRV reflects the balance between these — parasympathetic dominance produces high HRV, sympathetic dominance produces low HRV.
Low HRV is not a diagnosis — it is an objective marker indicating the body is in a state of physiological stress, regardless of whether the patient subjectively experiences stress. This is why HRV is clinically valuable: it measures biological load directly, not via symptom reporting.
| Age | Low | Normal | High | Status |
|---|---|---|---|---|
| 20–30 yrs | <40 | 40–80 | >80 | High capacity |
| 30–40 yrs | <35 | 35–70 | >70 | Normal |
| 40–50 yrs | <28 | 28–60 | >60 | Normal |
| 50–60 yrs | <22 | 22–50 | >50 | Monitor |
| 60+ yrs | <15 | 15–40 | >40 | Monitor |
Reference values based on ECG measurement at rest (5 min). Fit individuals typically have 20–30% higher values. Clinical interpretation requires context.
Low HRV is associated with a broad spectrum of clinical conditions. It is not a diagnosis — it is a biological signal pattern indicating that autonomic regulation is under load.
Systemic inflammation activates the sympathetic nervous system and suppresses vagal tone — directly reducing HRV. Low HRV can be the first objective sign of inflammatory load, often before CRP or other markers rise.
Patients with burnout and ME/CFS consistently show reduced HRV and parasympathetic dysfunction. HRV measurement provides an objective measure of recovery capacity independent of patient self-reporting.
Low HRV is an independent predictor of cardiovascular morbidity and mortality — stronger than many traditional risk factors. Prospective studies show significantly increased risk at RMSSD below 20 ms.
Nocturnal HRV reflects sleep quality more accurately than subjective sleep experience. Low nocturnal HRV indicates insufficient parasympathetic activation and impaired deep sleep phases.
Autonomic neuropathy — an early sign of metabolic dysfunction — manifests as reduced HRV. HRV analysis can identify autonomic dysfunction before a clinical diabetes diagnosis.
Depression, anxiety and PTSD are consistently associated with low HRV. Vagal tone — measured via HRV — correlates with emotion regulation and is a biological marker of psychological stress tolerance.
| Feature | MediBalans Clinical analysis |
Smartwatch Apple Watch, Garmin, Whoop |
|---|---|---|
| Measurement method | ECG — R-R intervals | PPG — optical sensor |
| Precision | ±1 ms | ±10–30 ms (motion-dependent) |
| Time domain analysis (RMSSD, SDNN) | ✓ Complete | ✗ Partial |
| Frequency domain analysis (LF, HF, LF/HF) | ✓ | ✗ |
| Non-linear analysis (SD1/SD2, DFA) | ✓ | ✗ |
| Clinical interpretation in context | ✓ Meet Mario AI | ✗ Algorithm |
| Integration with other biomarkers | ✓ GCR-based | ✗ |
| Longitudinal outcome tracking | ✓ Outcome marker | Limited |
Low HRV tells you the autonomic nervous system is under load. It does not tell you why. Chronic inflammation, nutrient deficiency, sleep disorder, autoimmunity, methylation dysfunction — all can produce identically low HRV. MediBalans uses HRV as one of several objective markers within the Global Constraint Rule — a clinical reasoning framework developed from 25,000+ patient cases that identifies the primary biological constraint and sequences treatment accordingly.
ECG-based HRV analysis with complete time, frequency and non-linear domain. Establishes your autonomic signature.
Meet Mario AI integrates HRV with intracellular nutrient status, genetics and clinical history to identify driving factors.
Treatment addresses the primary constraint — not the HRV value itself. HRV is used as an outcome marker confirming biological response.
HRV is measured at every follow-up visit. Improvement in HRV is objective confirmation that treatment is addressing the right constraint.
HRV measures the variation in time between heartbeats — not the heart rate itself. High HRV indicates a flexible, well-regulated autonomic nervous system with good parasympathetic activity. Low HRV indicates sympathetic dominance — the body is in constant activation rather than recovery. HRV is the most sensitive non-invasive measure of autonomic function and biological stress load.
HRV values vary considerably with age, sex and fitness. Generally: ages 20–40: 40–100 ms (RMSSD). Ages 40–60: 25–75 ms. Over 60: 15–50 ms. Fit individuals typically have 20–30% higher values. The most important factor is not a single value but the trend over time and the clinical context — a low value in an ME/CFS patient has different clinical significance than the same value in a fit 55-year-old.
Low HRV has many possible causes: chronic inflammation, autoimmunity, sleep disorder, nutrient deficiency (particularly magnesium and B vitamins), methylation dysfunction, metabolic dysfunction, psychological stress, cardiovascular disease and autonomic neuropathy. This is precisely why clinical HRV analysis must be combined with broader diagnostics — the HRV value tells you the autonomic nervous system is under load, not why.
Consumer devices measure HRV via PPG sensor (optical photoplethysmography at the wrist) — an indirect method with significant measurement error, particularly during movement. Clinical HRV measurement uses ECG-based R-R interval analysis with ±1 ms precision. Most smartwatches also only report a summary score and miss frequency domain analysis (LF/HF ratio) and non-linear analysis that are clinically relevant.
HRV improves when the underlying autonomic imbalance is addressed. General factors: aerobic exercise, sleep optimisation, anti-inflammatory diet, and treatment of underlying conditions. But if low HRV is driven by a specific constraint — such as methylation dysfunction or intracellular magnesium deficiency — targeted treatment is required. MediBalans identifies the primary driving factor and measures HRV response longitudinally as a confirmed outcome marker.
No referral is required. MediBalans accepts patients directly. Book an initial consultation where Meet Mario AI analyses your clinical presentation and determines whether HRV analysis is clinically indicated.
An initial consultation gives you objective data on your autonomic function, stress load and recovery capacity — and a clinical plan for what is actually driving your biology.